Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7807339

Cn1c(=O)c(-c2cn(Cc3cccc(CN)c3)c3ccccc23)nc2ccccc21.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 8/20 0.43
PDE4B Q07343 8/20 0.43
PDE4C Q08493 8/20 0.43
PDE4D Q08499 8/20 0.43
PDE3B Q13370 4/20 0.43
PDE3A Q14432 4/20 0.43
TPSAB1 Q15661 7/20 0.42
MAPT P10636 2/20 0.42
SIRT2 Q8IXJ6 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7815420 0.94 PDE4A (0.45) PDE4APDE4BPDE4CPDE4DPDE3B
Trifluoroacetic Acid SCHEMBL7818314 0.84 CAMK2D (0.48) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL8516249 0.78 F2RL3 (0.40) PDE4APDE4BPDE4CPDE4DPDE3B
Acetic Acid SCHEMBL7807324 0.77 IDO1 (0.43) PDE4APDE4BPDE4CPDE4DPDE3B
Trifluoroacetic Acid SCHEMBL7806936 0.77 CFTR (0.49) ALDH1A1
Acetic Acid SCHEMBL7815108 0.76 CAMK2D (0.51) MAPTMEN1HTTRAB9AKMT2A
SCHEMBL7657926 0.75 USP2 (0.41) PDE4APDE4BPDE4CPDE4DPDE3B
Trifluoroacetic Acid SCHEMBL7815291 0.75 CAMK2D (0.46) MAPTALDH1A1
Trifluoroacetic Acid SCHEMBL8516316 0.74 USP2 (0.47) TPSAB1MAPTMEN1KMT2AALDH1A1
Acetic Acid SCHEMBL7657913 0.74 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025043-A1 New pharmaceutical active compounds ASTRA AKTIEBOLAG, A SWEDEN CORPORATION 2001-09-27 US claimed
US-6271231-B1 Pharmaceutically active compounds ASTRA AKTIEBOLAG (SE) 2001-08-07 US claimed
US-20010025043-A1 New pharmaceutical active compounds ASTRA AKTIEBOLAG, A SWEDEN CORPORATION 2001-09-27 US disclosed
US-6271231-B1 Pharmaceutically active compounds ASTRA AKTIEBOLAG (SE) 2001-08-07 US disclosed
EP-0929551-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS Astra Aktiebolag (publ) (SE) 1999-07-21 EP disclosed
WO-1998013368-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRA AKTIEBOLAG (PUBL) (SE) 1998-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025043-A1 New pharmaceutical active compounds CSNK1A1, CSNK1G1, CSNK2A1 PDE4A 228/4885PDE4B 342/4885PDE4C 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.